This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neonatology and Infant Care  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Thomas B. Newman, MD, MPH; Petra Liljestrand, PhD; Gabriel J. Escobar, MD

Arch Pediatr Adolesc Med. 2005;159:113-119.

Objectives  (1) To validate a previously reported risk index for predicting total serum bilirubin (TSB) levels of 25 mg/dL (428 µmol/L) or higher; (2) to combine a subset of this index with TSB levels measured at less than 48 hours to predict subsequent TSB levels of 20 mg/dL (342 µmol/L) or higher.

Design  Nested case-control study using electronic and paper records (study 1). Retrospective cohort study using electronic records only (study 2).

Setting  Northern California Kaiser Permanente hospitals.

Patients  Subjects for both studies were newborns weighing 2000 g or more and of 36 weeks’ or more gestation. The validation study included 67 cases born 1997-1998 who developed TSB levels of 25 mg/dL or higher at less than 30 days and 208 randomly selected control subjects. Subjects for study 2 were 5706 newborns who both were discharged from the hospital and had a TSB level measured at less than 48 hours.

Results  The risk index performed similarly in the validation group, born in 1997-1998, and the derivation group, born in 1995-1996 (area under the receiver operating characteristic curve = 0.83 vs 0.84). Of the 5706 newborns with TSB levels measured before 48 hours, 270 (4.7%) developed a TSB level of 20 mg/dL or higher. Of these, 254 (94%) had a TSB level at the 75th percentile or higher at less than 48 hours. The risk index improved prediction over the TSB level alone, largely owing to the effect of gestational age. For example, for those with a TSB level at the 95th percentile or higher at less than 48 hours, the risk increased from 9% for newborns born at 40 weeks’ or more gestation to 42% for those born at 36 weeks.

Conclusion  Clinical risk factors significantly improve prediction of subsequent hyperbilirubinemia compared with early TSB levels alone, especially in those with early TSB levels above the 75th percentile.

Author Affiliations: Departments of Epidemiology and Biostatistics (Drs Newman and Liljestrand) and Pediatrics (Dr Newman), School of Medicine, University of California, San Francisco; the Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif (Drs Newman, Liljestrand and Escobar); and the Department of Pediatrics, Kaiser Permanente Medical Center, Walnut Creek, Calif (Dr Escobar).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transcutaneous Bilirubin Nomograms: A Systematic Review of Population Differences and Analysis of Bilirubin Kinetics
De Luca et al.
Arch Pediatr Adolesc Med 2009;163:1054-1059.
ABSTRACT | FULL TEXT  

Complex Multifactorial Nature of Significant Hyperbilirubinemia in Neonates
Watchko et al.
Pediatrics 2009;124:e868-e877.
ABSTRACT | FULL TEXT  

Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
Kuzniewicz et al.
Pediatrics 2009;124:1031-1039.
ABSTRACT | FULL TEXT  

Systematic Review of Screening for Bilirubin Encephalopathy in Neonates
Trikalinos et al.
Pediatrics 2009;124:1162-1171.
ABSTRACT | FULL TEXT  

Screening of Infants for Hyperbilirubinemia to Prevent Chronic Bilirubin Encephalopathy: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Pediatrics 2009;124:1172-1177.
ABSTRACT | FULL TEXT  

Hyperbilirubinemia in the Newborn Infant >=35 Weeks' Gestation: An Update With Clarifications
Maisels et al.
Pediatrics 2009;124:1193-1198.
FULL TEXT  

Visual assessment of jaundice in term and late preterm infants
Keren et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2009;94:F317-F322.
ABSTRACT | FULL TEXT  

Predicting Response of Vitreous Hemorrhage after Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) in Patients with Diabetes
Bhavsar et al.
IOVS 2008;49:4219-4225.
ABSTRACT | FULL TEXT  

A Comparison of Alternative Risk-Assessment Strategies for Predicting Significant Neonatal Hyperbilirubinemia in Term and Near-Term Infants
Keren et al.
Pediatrics 2008;121:e170-e179.
ABSTRACT | FULL TEXT  

Predischarge Risk Assessment for Severe Neonatal Hyperbilirubinemia
Keren and Bhutani
NeoReviews 2007;8:e68-e76.
ABSTRACT | FULL TEXT  

Preventable Newborn Readmissions Since Passage of the Newborns' and Mothers' Health Protection Act
Paul et al.
Pediatrics 2006;118:2349-2358.
ABSTRACT | FULL TEXT  

Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border.
Maisels and Newman
CMAJ 2006;175:599-599.
FULL TEXT  

Transcutaneous Bilirubin Levels in the First 96 Hours in a Normal Newborn Population of >=35 Weeks' Gestation
Maisels and Kring
Pediatrics 2006;117:1169-1173.
ABSTRACT | FULL TEXT  

Clinical assessment of neonatal hyperbilirubinaemia * Author's reply
Kanjilal et al.
Arch. Dis. Child. 2005;90:1202-1202.
FULL TEXT